In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in ...

Cingulate (CING) reported that as of December 31, 2024, the company had approximately $12.2M in cash and cash equivalents, a $12.1M increase ...

Cingulate (NASDAQ:CING – Get Free Report) is expected to release its earnings data before the market opens on Monday, March ...

March 04, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

In a report released today, Boobalan Pachaiyappan from Roth MKM maintained a Buy rating on Cingulate Inc (CING – Research Report), with a price ...

Next time you feel an itch, remember that your brain's vast network of neurons informs it whether it is an itch or pain. A ...

Study reveals how diabetes rewires the brain, affecting memory and reward processing by linking high blood sugar to changes ...

UNLV research team says high blood sugar levels appear to weaken function in key part of brain, mimicking Alzheimer’s.

KANSAS CITY, Kan., March 04, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery ...

Cingulate Inc是一家临床阶段的生物制药公司。该公司专注于利用精确定时释放（PTR）药物输送平台技术开发，制造和商业化药品 ...